Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing: earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures gives cross-border investors faster access to Tokyo-listed disclosures.
This corporate disclosure from Otsuka Holdings Co.,Ltd. was processed by Pulse News Wire on May 7, 2026. It represents a primary source document for Japanese Corporate sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
TOKYO, May 07 (Pulse News Wire) – Otsuka Holdings CO.,LTD. (4578.T) announced that its subsidiary, Otsuka Pharmaceutical Factory America, Inc. (OPFA), resolved to increase capital in its subsidiary Ot
View all Otsuka Holdings Co.,Ltd. disclosures →
Otsuka Holdings Co.,Ltd. [4578.T]
TOKYO, May 07 (Pulse News Wire) – Otsuka Holdings CO.,LTD. (4578.T) announced that its subsidiary, Otsuka Pharmaceutical Factory America, Inc.
(OPFA), resolved to increase capital in its subsidiary Otsuka Clinical Nutrition America LLC (OCNA) during a board meeting held on May 07, 2026. TheOCNA,1.3,OCNA1.3OCNA202625,Howard Lane 13000, 20266,.
🟡 Confidence: Standard AI-translated content.